Published in Health and Medicine Week, January 31st, 2005
Dextofisopam provided relief in both women and men with either diarrhea-predominant or alternating-type IBS. Some symptoms were relieved as early as the second day of treatment. Dextofisopam was well tolerated and did not cause constipation.
This double-blind, placebo-controlled phase 2 trial under U.S. IND enrolled 141 patients at centers...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.